Literature DB >> 29768970

Neurologic manifestations of antiphospholipid syndrome.

I F Ricarte1, L A Dutra1,2, F F Abrantes1, F F Toso1, O G P Barsottini1, G S Silva1,2, A W S de Souza3, D Andrade3.   

Abstract

Neurological involvement in antiphospholipid antibody syndrome (APS) is common, and its occurrence increases morbidity and mortality. Patients may present variable neurological involvement, such as cerebrovascular disease, cognitive dysfunction, headache, seizures, movement disorders, multiple sclerosis-like syndrome, transverse myelitis and ocular symptoms. Most neurological manifestations are associated with thrombosis of the microcirculation or of large vessels; nonetheless, there is compelling evidence suggesting that, in some cases, symptoms are secondary to an immune-mediated pathogenesis, with direct binding of aPL on neurons and glia. Herein we describe clinical characteristics and management of neurological APS manifestations.

Entities:  

Keywords:  APS; Antiphospholipid syndrome; antiphospholipid antibodies; central nervous system; neurological manifestations; stroke

Mesh:

Substances:

Year:  2018        PMID: 29768970     DOI: 10.1177/0961203318776110

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  9 in total

1.  Multiple embolic strokes in primary antiphospholipid syndrome.

Authors:  Jesus A Garcia-Diaz; Ricardo Alvarez-Santana; Mara Escudero-Salamanca; Eulo Lupi-Herrera; Nilda Espinola-Zavaleta
Journal:  Eur J Rheumatol       Date:  2020-07-21

2.  Definition and treatment approach of non-criteria clinical manifestations of antiphospholipid syndrome.

Authors:  Ayten Yazıcı
Journal:  Eur J Rheumatol       Date:  2020-10

Review 3.  Neurologic Manifestations of Catastrophic Antiphospholipid Syndrome.

Authors:  Rafid Mustafa
Journal:  Curr Neurol Neurosci Rep       Date:  2022-08-30       Impact factor: 6.030

4.  Neuroimaging features of antiphospholipid antibody-related stroke compared with atrial fibrillation-related stroke.

Authors:  Wookjin Yang; Dong-Wan Kang; Jeong-Min Kim; Keun-Hwa Jung; Seung-Hoon Lee
Journal:  Sci Rep       Date:  2022-07-08       Impact factor: 4.996

5.  Dementia in a patient with autoimmune disease and hypercoagulable state worsened by COVID-19 vaccination: A case report.

Authors:  Amelia Nur Vidyanti; Mira Tamila Nurul Maulida Awaliyah; Aditya Rifqi Fauzi; Indra Sari Kusuma Harahap; Deshinta Putri Mulya
Journal:  Ann Med Surg (Lond)       Date:  2022-06-03

Review 6.  Movement Disorders and Hematologic Diseases.

Authors:  Roshni Abee Patel; Deborah A Hall; Sheila Eichenseer; Meagan Bailey
Journal:  Mov Disord Clin Pract       Date:  2020-12-29

Review 7.  Antiphospholipid Syndrome and the Neurologist: From Pathogenesis to Therapy.

Authors:  Thomas Fleetwood; Roberto Cantello; Cristoforo Comi
Journal:  Front Neurol       Date:  2018-11-26       Impact factor: 4.003

8.  The burden of headache following aneurysmal subarachnoid hemorrhage: a prospective single-center cross-sectional analysis.

Authors:  Torge Huckhagel; Regine Klinger; Nils Ole Schmidt; Jan Regelsberger; Manfred Westphal; Patrick Czorlich
Journal:  Acta Neurochir (Wien)       Date:  2020-02-04       Impact factor: 2.216

Review 9.  Neurologic Manifestations of the Antiphospholipid Syndrome - an Update.

Authors:  Miguel Leal Rato; Matilde Bandeira; Vasco C Romão; Diana Aguiar de Sousa
Journal:  Curr Neurol Neurosci Rep       Date:  2021-06-14       Impact factor: 5.081

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.